-
1
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
Published 2021-02-01Subjects: Get full text
Article -
2
-
3
Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
Published 2021-03-01Subjects: Get full text
Article -
4
Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor
Published 2024-02-01Subjects: Get full text
Article -
5
Long-Term Outcomes in Real Life of Lumacaftor–Ivacaftor Treatment in Adolescents With Cystic Fibrosis
Published 2021-11-01Subjects: Get full text
Article -
6
Impact of Airway Inflammation on the Efficacy of CFTR Modulators
Published 2021-11-01Subjects: Get full text
Article -
7
Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial
Published 2020-10-01Subjects: “…cystic fibrosis transmembrane conductance regulator (cftr) potentiator…”
Get full text
Article -
8
Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
Published 2019-08-01Subjects: Get full text
Article -
9
New Insights into the Binding Features of F508del CFTR Potentiators: A Molecular Docking, Pharmacophore Mapping and QSAR Analysis Approach
Published 2020-12-01Subjects: “…CFTR potentiators…”
Get full text
Article